Michelle Weese
EVP, Corporate Affairs | Independent Board Director
Novartis•United States
View LinkedIn ProfileExecutive Overview
Michelle Weese is a seasoned c-suite multi-function leader who is highly experienced in finding competitive advantage through managing calculated risk and opportunity. With proven ability to understand and leverage accelerated changes in marketplace dynamics, she drives agility and adds sustainable value by capturing and optimizing real-time insights. Recognized as a change agent, Michelle excels at turnarounds, creating opportunities and leading teams for flawless program execution. Michelle has depth of experience in delivering superior ESG performance and is uniquely able to drive purpose as the heart of company culture. She is acknowledged as a strong problem solver who understands the issues and complexities of both private and public companies and has a proven track record of leading both Corporate and Legal Affairs, including managing General Counsels, Regulatory, Compliance, Security, Corporate Communications and Corporate Marketing, Government and Public Affairs and ESG. Michelle excels at strategic planning, concept development, key opportunity identification, launching new products and services, issues and crisis management, government/community affairs, acquisition/merger communications, reputation management and effectively leading corporate transformation.
Career Timeline
- NovartisCurrentJul 2023–Present· 3 yrs 2 mos
- Chief Corporate Affairs OfficerCurrentJul 2023–Present
- Jun 2021–Jul 2023· 2 yrs 1 mo
- EVP Corporate AffairsJun 2021–Jul 2023
- 2019–Jun 2021· 2 yrs 5 mos
- General Secretary, North America2019–Jun 2021
- 2009–2019· 10 yrs
- Partner/CEO2009–2019
- 1999–2009· 10 yrs
- Global Head of Corporate Communications2006–2009
- SVP Corporate Affairs2003–2007
- VP Public Relations2001–2003
- PR Director1999–2001
- 1994–1999· 5 yrs
- Director, Corporate Communications1994–1999